Letter by Pinheiro et al Regarding Article, " Unexpected Effect of Proton Pump Inhibitors: Elevation of the Cardiovascular Risk Factor Asymmetric Dimethylarginine"

被引:9
|
作者
Pinheiro, Lucas C. [1 ]
Amaral, Jefferson H. [1 ]
Tanus-Santos, Jose E. [1 ]
机构
[1] Preto Univ Sao Paulo, Dept Pharmacol, Ribeirao Preto, Brazil
关键词
SODIUM-NITRITE;
D O I
10.1161/CIRCULATIONAHA.113.005307
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:E427 / E427
页数:1
相关论文
共 50 条
  • [1] Letter by Chyrchel et al Regarding Article, " Unexpected Effect of Proton Pump Inhibitors: Elevation of the Cardiovascular Risk Factor Asymmetric Dimethylarginine"
    Chyrchel, Bernadeta
    Chyrchel, Michal
    Surdacki, Andrzej
    [J]. CIRCULATION, 2014, 129 (13) : E425 - E425
  • [2] Letter by Montenegro and Lundberg Regarding Article, " Unexpected Effect of Proton Pump Inhibitors: Elevation of the Cardiovascular Risk Factor Asymmetric Dimethylarginine"
    Montenegro, Marcelo F.
    Lundberg, Jon O.
    [J]. CIRCULATION, 2014, 129 (13) : E426 - E426
  • [3] Response to Letters Regarding Article, " Unexpected Effect of Proton Pump Inhibitors: Elevation of the Cardiovascular Risk Factor Asymmetric Dimethylarginine"
    Ghebremariam, Yohannes T.
    LePendu, Paea
    Lee, Jerry C.
    Erlanson, Daniel A.
    Slaviero, Anna
    Shah, Nigam H.
    Leiper, James M.
    Cooke, John P.
    [J]. CIRCULATION, 2014, 129 (13) : E428 - E428
  • [4] Unexpected Effect of Proton Pump Inhibitors: Elevation of the Cardiovascular Risk Factor Asymmetric Dimethylarginine
    Ghebremariam, Yohannes T.
    LePendu, Paea
    Lee, Jerry C.
    Erlanson, Daniel A.
    Slaviero, Anna
    Shah, Nigam H.
    Leiper, James
    Cooke, John P.
    [J]. CIRCULATION, 2013, 128 (08) : 845 - 853
  • [5] Response by Abrahami et al to letter regarding article 'Proton pump inhibitors and risk of colorectal cancer'
    Abrahami, Devin
    Azoulay, Laurent
    [J]. GUT, 2022, 71 (08) : 1690 - 1691
  • [6] Letter by Marlicz et al Regarding Article, "Proton Pump Inhibitors Accelerate Endothelial Senescence"
    Marlicz, Wojciech
    Koulaouzidis, Anastasios
    Loniewski, Igor
    Koulaouzidis, George
    [J]. CIRCULATION RESEARCH, 2016, 119 (02) : E31 - E32
  • [7] Human dimethylarginine dimethylaminohydrolase 1 inhibition by proton pump inhibitors and the cardiovascular risk marker asymmetric dimethylarginine: in vitro and in vivo significance
    Tommasi, S.
    Elliot, D. J.
    Hulin, J. A.
    Lewis, B. C.
    McEvoy, M.
    Mangoni, A. A.
    [J]. SCIENTIFIC REPORTS, 2017, 7
  • [8] Human dimethylarginine dimethylaminohydrolase 1 inhibition by proton pump inhibitors and the cardiovascular risk marker asymmetric dimethylarginine: in vitro and in vivo significance
    S. Tommasi
    D. J. Elliot
    J. A. Hulin
    B. C. Lewis
    M. McEvoy
    A. A. Mangoni
    [J]. Scientific Reports, 7
  • [9] Letter by Zheng et al Regarding Article, "Cerebrovascular Outcomes With Proton Pump Inhibitors and Thienopyridines: A Systematic Review and Meta-Analysis"
    Zheng, Bing-Kun
    Niu, Peng-Peng
    [J]. STROKE, 2018, 49 (04) : E170 - E170
  • [10] Letter by Li et al Regarding Article, "Severe Infection and Risk of Cardiovascular Disease: A Multicohort Study"
    Li, Sha
    Qian, Jie
    Li, Jian-Jun
    [J]. CIRCULATION, 2023, 148 (19) : 1507 - 1508